Receptors, Thrombin, antagonists & inhibitors

Name
Receptors, Thrombin, antagonists & inhibitors
Accession Number
DBCAT001737
Description

Not Available

Drugs
DrugDrug Description
VorapaxarA platelet aggregation inhibitor used to reduce thrombotic cardiovascular events in patients with a history of myocardial infarction (MI) or peripheral arterial disease (PAD).
AtopaxarAtopaxar has been investigated for the treatment of Coronary Artery Disease and Acute Coronary Syndrome.
Drugs & Drug Targets
DrugTargetType
VorapaxarProteinase-activated receptor 1target
VorapaxarCytochrome P450 3A4enzyme
VorapaxarCytochrome P450 2J2enzyme
VorapaxarP-glycoprotein 1transporter